Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia - Wikidata - awgldk - TriplyDB

Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia

Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia

http://www.wikidata.org/entity/Q36571783

about

Recent advances and novel treatment paradigms in acute lymphocytic leukemia The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin.Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL.Oligoclonality and new agent evaluation in acute lymphoblastic leukaemia.Ikaros: Exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia.Ph-like acute lymphoblastic leukemia.Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults.Genetic Basis of Acute Lymphoblastic Leukemia.Treatment of Young Adults with Acute Lymphoblastic Leukemia.Selective Expression of Flt3 within the Mouse Hematopoietic Stem Cell Compartment.Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.Philadelphia chromosome-like acute lymphoblastic leukemia.Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia.Activation-induced cytidine deaminase prevents pro-B cell acute lymphoblastic leukemia by functioning as a negative regulator in Rag1 deficient pro-B cells.Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.Stromal Lkb1 deficiency leads to gastrointestinal tumorigenesis involving the IL-11-JAK/STAT3 pathway.Development of acute lymphoblastic leukemia with IgH-EPOR in a patient with secondary erythrocytosis.JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders.Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia.How is the Ph-like signature being incorporated into ALL therapy?New pathogenic mechanisms induced by germline erythropoietin receptor mutations in primary erythrocytosis.Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure.Inhibiting Janus Kinase 1 and BCL-2 to treat T cell acute lymphoblastic leukemia with IL7-Rα mutations.Philadelphia Chromosome-like Acute Lymphoblastic Leukemia.Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer.The genetic basis and cell of origin of mixed phenotype acute leukaemia Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome

P2860

Q28078076-14683294-F2BF-426B-998D-8047BE1E3ECB Q33440994-F1CE38B2-DFFD-4ABF-9713-71A073AFA784 Q37408629-73755921-61EF-4352-9E7D-FB6392EEF3BF Q37483972-39D78D02-37D2-40A7-9803-0E396C1264BF Q37739018-B5010B03-483B-4105-847A-2B7D327C907C Q38843371-BBD1F49A-A544-446E-B7B0-14F725303F3D Q39014321-9FA470D6-023D-4B0C-A952-C9718480A3E2 Q39027852-C45F93EF-7B86-4DBA-96FC-20AA18D91A53 Q39041475-2A6EDE67-B832-4689-A7F6-7AF3578572D3 Q39128765-C4D349D4-D3B4-41E5-8BC5-7518F497A572 Q39180500-549EABC1-E638-4DD9-8972-0D59204879B0 Q39206217-FA626673-57E7-4445-B6C3-D54914A31AC4 Q42229089-506E56D9-7E80-40ED-9ECC-0196EDB0041C Q42324924-67AE2A58-7303-4AB3-9741-088E4159F59C Q43431904-6C573BBB-9DFD-45E6-8D2C-8FAAB9C65505 Q44018556-CC83A9D5-734D-4FE8-8D4F-2A177878F7B7 Q45630172-E7EC7305-E353-41FA-AB1C-B9B94BF7E568 Q46711660-96759F30-B688-4EE1-B5DF-BB819C8090A6 Q47373003-A174C82D-E4BB-450C-BB8C-0D1DD5B4A126 Q48103291-4EC34B81-B40C-4AA0-85D8-A4A5A8428EE7 Q48109284-C85738C7-D07A-43C8-A6C0-D63BC74FA74C Q50001759-5FE359D3-647C-49DF-88DE-CD1FFAB8114F Q50098629-A25D7BE2-86A8-4E20-B79F-3B75BA9F6503 Q50167563-93E8AAFE-458E-43C7-9686-2BFE5E3071BB Q54109030-8AFA1E5B-461B-4249-8C27-DD8245C23A6D Q54977480-176BA6E3-EA25-4D7D-80B7-499EB38E0FAB Q54989161-79C0A045-C2A0-453C-B2CB-CA91BED0301B Q55084775-D8740139-35D4-465E-A91A-8CD2CAF8FF4D Q57158107-E8017F78-F7CE-4E95-8D1A-7E919E17CF76 Q59129106-B68B8162-61DB-473B-A37F-5AD041EC4D7D

P2860

Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia

http://www.wikidata.org/entity/Q36571783

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia

@ast

Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia

@en

type

label

Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia

@ast

Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia

@en

prefLabel

Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia

@ast

Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia

@en

P1433

Q36571783-0BFD5259-B054-44CC-88EE-533D737380B5

P1476

Q36571783-DE51118B-67CE-4ABC-992D-4309D85B2657

P2093

Q36571783-05AD0872-7B47-4368-8771-6EA4470BB670

Q36571783-0BB07820-C8E2-4418-9A0E-703EF973751C

Q36571783-0BD97428-C156-44D4-BA66-7EA46A755760

Q36571783-0D7254F6-BE98-4BE4-92CC-7D712986189F

Q36571783-297A3E13-044C-4199-9394-8C9153EF48B3

Q36571783-2BBA52F9-1C6B-4F92-8DB0-0522339908A7

Q36571783-2EF1F31C-9A95-4179-886A-847367044276

Q36571783-3C8F2004-1013-447C-A603-08EA82B6260A

Q36571783-4DCE7457-8A14-4C37-86ED-9BB072DD0434

Q36571783-5846471C-C727-4E48-AB66-955DE977BFA5

P2860

Q36571783-03B0376A-797F-4069-827A-76216DBD1628

Q36571783-08F8F07C-1550-41F2-AE7B-EC4E296E45DD

Q36571783-15527D40-D047-4923-BE72-358A9C677623

Q36571783-180B1C35-191A-4347-8A66-44C12A499448

Q36571783-19018782-96A1-4C58-9EC4-0E9041A2ADA2

Q36571783-2363FCC3-D43D-4D44-A9A1-DC93CF2771F4

Q36571783-28B61CAC-A81F-4B65-979F-79D374D764D4

Q36571783-2CA21FCD-3311-4FC6-8810-F771591C92E4

Q36571783-2DBF2D81-178B-47D7-B89B-9EFA6A0AB3E3

Q36571783-31C70BAC-9B33-4BF6-97CB-017CC4D1FF47

P304

Q36571783-F7C83A5F-DF54-41FD-95C1-DDE02497DC26

P31

Q36571783-1B72D325-F0C5-4877-B09E-3094DFEE16A8

P356

Q36571783-CA061CAB-0C9B-4512-B9AF-EA139D523034

P433

Q36571783-45C50514-4553-4E40-98B9-0EA4B5D40624

P478

Q36571783-D397E758-13AA-4CE7-B290-E1D2228AB657

P50

Q36571783-025EF5FB-D771-41B3-8190-FBF118B5282F

Q36571783-02FED4C7-AC71-409A-9562-F1195FFE6276

Q36571783-0EFEA54D-2A1D-48FE-B61D-4A0687D7DDA1

Q36571783-17091011-92A0-4E78-901B-03FBE2C16C37

Q36571783-480F99A8-755B-4B41-9271-06A5E1389552

Q36571783-4A8292F7-7EDD-476C-BF74-FF9300840EDB

Q36571783-500B278C-885C-4E63-9CC7-24018E8D84A1

Q36571783-503CBB51-DA4F-4AEA-8651-36A8941555C3

Q36571783-DE0FE309-FAE4-444E-A915-9F970B75E134

Q36571783-F0CBF6A6-BA09-4535-ADF4-E6C4BA247155

P577

Q36571783-A9B7BDBD-6379-417B-927A-695A561409B3

P698

Q36571783-EFF2EC83-BDAE-447E-AFD9-D96CF84B2B0E

P921

Q36571783-363F74E4-884B-408F-A75D-2ABC675BBF1A

Q36571783-F2F9E3AF-7A7A-4503-9CA7-6869A9D2CCEF

P932

Q36571783-6C421BE3-3AC0-4A91-B2CC-89763B39F3D6

P356

J.CCELL.2015.12.013

P1433

P1476

Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia

@en

P2093

Charles G Mullighan

http://www.w3.org/2001/XMLSchema#string

Cheryl L Willman

http://www.w3.org/2001/XMLSchema#string

Debbie Payne-Turner

http://www.w3.org/2001/XMLSchema#string

Donald Yergeau

http://www.w3.org/2001/XMLSchema#string

Elisabeth M Paietta

http://www.w3.org/2001/XMLSchema#string

I-Ming L Chen

http://www.w3.org/2001/XMLSchema#string

Jacob M Rowe

http://www.w3.org/2001/XMLSchema#string

Jaeseung C Kim

http://www.w3.org/2001/XMLSchema#string

James R Downing

http://www.w3.org/2001/XMLSchema#string

Janis Racevskis

http://www.w3.org/2001/XMLSchema#string

P2860

Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine

Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia.

Advances in understanding the pathogenesis of primary familial and congenital polycythaemia

Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.

Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia

Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias.

A phase I/II study of the Janus kinase (JAK)1 and 2 inhibitor ruxolitinib in patients with relapsed or refractory acute myeloid leukemia

P304

186-200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCELL.2015.12.013

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Kelly McCastlain

Stephen P Hunger

Ilaria Iacobucci

Marina Konopleva

Martin S Tallman

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26859458

http://www.w3.org/2001/XMLSchema#string

P921

P932

4750652

http://www.w3.org/2001/XMLSchema#string